Dr. Magliocco to present at the 14th Annual World CB & CDx Meeting

Dr. Magliocco will be presenting on the topic of next generation digital pathology.

Anthony MaglioccoSeptember 2, 2024

Protean Named as Finalist in GrowFL Companies to Watch

Protean is proud to be named by GrowFL as one of the top Florida companies to watch.

Anthony MaglioccoAugust 16, 2024

Interview with Chris Roberts from Protean's Joint Venture Aventa Genomics

Chris Roberts of Aventa Genomics, the joint venture between Protean and Arima Genomics was interviewed on the groundbreaking FusionPlus test.

Anthony MaglioccoApril 24, 2024

Protean Presents Research Utilizing NGS at AMP 2023

In this study, we analyzed 80 pan-cancer cases that underwent comprehensive genomic testing and compared the auto-classified variant tiers among four globally-available software solutions for variant interpretation from Roche, SOPHiA GENETICS, QIAGEN, and Genoox.

Anthony MaglioccoMarch 1, 2024

Dr. Magliocco Featured in Pathology Spotlight

Anthony Magliocco, CEO of Protean has been featured in the December Member Spotlight for the Florida Society of Pathologists.

Anthony MaglioccoJanuary 9, 2024

Protean Presents Multiple Abstracts at AMP

Protean congratulates Roy Khalife and Saar Peles on their research, presented at AMP 2023.

Anthony MaglioccoNovember 30, 2023